相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of NKG2D Expression and Signaling by Endocytosis
Rosa Molfetta et al.
TRENDS IN IMMUNOLOGY (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
Natural killer cell memory in infection, inflammation and cancer
Adelheid Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Early T Cell Activation: integrating Biochemical, Structural, and Biophysical Cues
Bernard Malissen et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Weiwen Deng et al.
SCIENCE (2015)
MICA polymorphism: biology and importance in cancer
Dan Chen et al.
CARCINOGENESIS (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Growth Rate Analysis and Efficient Experimental Design for Tumor Xenograft Studies
Gregory Hather et al.
CANCER INFORMATICS (2014)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire
Sam Sheppard et al.
BLOOD (2013)
Activating natural cytotoxicity receptors of natural killer cells in cancer and infection
Joachim Koch et al.
TRENDS IN IMMUNOLOGY (2013)
New prospects on the NKG2D/NKG2DL system for oncology
Evelyn Ullrich et al.
ONCOIMMUNOLOGY (2013)
Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function
J. De Boniface et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction
Maya Caroline Andre et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Elucidating the Mechanisms of Influenza Virus Recognition by Ncr1
Ariella Glasner et al.
PLOS ONE (2012)
Intact NKG2D-Independent Function of NK Cells Chronically Stimulated with the NKG2D Ligand Rae-1
Marine Champsaur et al.
JOURNAL OF IMMUNOLOGY (2010)
NKG2D Initiates Caspase-Mediated CD3ζ Degradation and Lymphocyte Receptor Impairments Associated with Human Cancer and Autoimmune Disease
Nobuyoshi Hanaoka et al.
JOURNAL OF IMMUNOLOGY (2010)
DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivo
Ilaria Tassi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Altered NK Cell Development and Enhanced NK Cell-Mediated Resistance to Mouse Cytomegalovirus in NKG2D-Deficient Mice
Biljana Zafirova et al.
IMMUNITY (2009)
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
Tadepally Lakshmikanth et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
David H. Raulet et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways
Jerome D. Coudert et al.
BLOOD (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
Evolutionary struggles between NK cells and viruses
Lewis L. Lanier
NATURE REVIEWS IMMUNOLOGY (2008)
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46
Thierry Walzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Soluble MICA in malignant diseases
S Holdenrieder et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
DE Oppenheim et al.
NATURE IMMUNOLOGY (2005)
NKp30 (NCR3) is a pseudogene in 12 inbred and wild mouse strains, but an expressed gene in Mus caroli
M Hollyoake et al.
MOLECULAR BIOLOGY AND EVOLUTION (2005)
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo
K Wiemann et al.
JOURNAL OF IMMUNOLOGY (2005)
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells
JD Coudert et al.
BLOOD (2005)
Down-regulation of ζ-chain expression in T cells:: a biomarker of prognosis in cancer?
TL Whiteside
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih et al.
BLOOD (2003)
Natural killer cell receptor signaling
LL Lanier
CURRENT OPINION IN IMMUNOLOGY (2003)
Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein
SA Welte et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation
S Gilfillan et al.
NATURE IMMUNOLOGY (2002)
Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D
A Diefenbach et al.
NATURE IMMUNOLOGY (2002)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding
HR Salih et al.
JOURNAL OF IMMUNOLOGY (2002)
The role of the NKG2D immunoreceptor in immune cell activation and natural killing
AM Jamieson et al.
IMMUNITY (2002)
Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family
A Steinle et al.
IMMUNOGENETICS (2001)
分享论文
